Clinical Trials List
2025-05-01 - 2029-06-30
Recruiting8
ICD-10I50.20
Unspecified systolic (congestive) heart failure
ICD-10I50.21
Acute systolic (congestive) heart failure
ICD-10I50.22
Chronic systolic (congestive) heart failure
ICD-10I50.23
Acute on chronic systolic (congestive) heart failure
ICD-10I50.30
Unspecified diastolic (congestive) heart failure
ICD-10I50.31
Acute diastolic (congestive) heart failure
ICD-10I50.32
Chronic diastolic (congestive) heart failure
ICD-10I50.33
Acute on chronic diastolic (congestive) heart failure
ICD-10I50.40
Unspecified combined systolic (congestive) and diastolic (congestive) heart failure
ICD-10I50.41
Acute combined systolic (congestive) and diastolic (congestive) heart failure
ICD-10I50.42
Chronic combined systolic (congestive) and diastolic (congestive) heart failure
ICD-10I50.43
Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure
ICD-10I50.9
Heart failure, unspecified
ICD-9428.0
Congestive heart failure
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 陳恬恩 Division of Cardiovascular Diseases
- 王宇澄 Division of Cardiovascular Diseases
- Lien-Cheng Hsiao Division of Cardiovascular Diseases
- 鍾偉信 Division of Cardiovascular Diseases
- Shih-Sheng Chang Division of Cardiovascular Diseases
- 林晏年 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wen-Chung Yu Division of Cardiovascular Diseases
- 黃偉銘 Division of Cardiovascular Diseases
- 吳承學 Division of General Internal Medicine
- 蔡泉財 Division of Cardiovascular Diseases
- 李慶威
- Hao-min Cheng 教學部
- Chern-En Chiang 臨床試驗科
- 張皓智 Division of Cardiovascular Diseases
- Tse-Min Lu Division of Family Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yung-Ta Kao Division of Cardiovascular Diseases
- 蕭卜源 Division of Cardiovascular Diseases
- 陳志維 Division of Cardiovascular Diseases
- 洪元 Division of Cardiovascular Diseases
- 陳彥舟 Division of Cardiovascular Diseases
- Chien-Yi Hsu Division of Cardiovascular Diseases
- 鄭宇倫 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shang-Ju Wu Division of Cardiovascular Diseases
- 簡育珊 Division of Cardiovascular Diseases
- 王奇彥 Division of Cardiovascular Diseases
- 何鴻鋆 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 王聖云 Division of Cardiovascular Diseases
- 黃宏凱 Division of Cardiovascular Diseases
- 李政良 Division of Cardiovascular Diseases
- 楊秉忠 Division of Cardiovascular Diseases
- 張惟智 Division of Cardiovascular Diseases
- 楊淵博 Division of Cardiovascular Diseases
- 陳美綾 Division of Cardiovascular Diseases
- 廖英傑 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chun-Yuan Chu Division of Cardiovascular Diseases
- Ye-Hsu Lu Division of Cardiovascular Diseases
- 吳韋璁 Division of Cardiovascular Diseases
- 黃天祈 Division of Cardiovascular Diseases
- Wei-Chung Tsai Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
70 participants
-
Global
6000 participants
